Liver Dysfunction by Model for End-Stage Liver Disease Score Improves Mortality Prediction in Injured Patients With Cirrhosis

被引:10
|
作者
Corneille, Michael G. [1 ]
Nicholson, Susannah
Richa, Jacqueline
Son, Colin
Michalek, Joel [2 ]
Wolf, Steven E.
Stewart, Ronald
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Surg, Div Trauma & Emergency Surg, San Antonio, TX 78229 USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA
关键词
Cirrhosis; Liver dysfunction; MELD; Model for End-Stage Liver Disease; Child-Pugh; Child's Classification; Child-Turcotte-Pugh; Trauma; End-stage liver disease; Outcomes; ISS; TRISS; CHILD-PUGH; MELD SCORE; SURVIVAL; TRAUMA; OUTCOMES;
D O I
10.1097/TA.0b013e31822311c5
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Cirrhosis is associated with poor outcomes in the trauma setting. We aimed to evaluate the utility of Model for End-Stage Liver Disease (MELD) in assessing additional mortality risk in trauma patients with cirrhosis. Methods: Injured patients with liver dysfunction were identified by hospital and trauma registry query. Presence of cirrhosis was confirmed by laparotomy, biopsy, or imaging. MELD classification, Child-Turcotte-Pugh (CTP) classification, Injury Severity Score (ISS), and Trauma ISS (TRISS) were recorded, and the primary outcome variable was hospital mortality. We assessed the validity of the four scoring systems in prediction of mortality, individually and in combinations, by comparing the areas under receiver operating characteristic curves (AUC), which is the probability, for scores that increase with the risk of death that a randomly chosen deceased subject will score higher than a randomly chosen living subject. Results: A total of 163 patients with confirmed cirrhosis were included. ISS (AUC = 0.849, p < 0.001) and TRISS (AUC = 0.826, p < 0.001) were the strongest predictors of mortality. MELD (AUC = 0.725) was not a significantly stronger predictor of mortality than CTP (AUC = 0.639; p = 0.38). ISS + MELD (AUC = 0.891) and ISS + CTP (AUC = 0.897) were stronger predictors than ISS alone (AUC = 0.849; p < 0.001) for both. The MELD score was more available from the records than the CTP score (91.4% vs. 75.5%). Conclusion: In trauma patients with cirrhosis, a score that evaluates the degree of liver dysfunction enhances the ability of ISS alone to predict mortality. The MELD score is more readily available than the CTP score for the prediction of mortality in trauma patients.
引用
收藏
页码:6 / 11
页数:6
相关论文
共 50 条
  • [21] Racial Differences in Liver Cirrhosis-Related Mortality Among Patients with Model for End-Stage Liver Disease Sodium Score (MELDNa) ≤ 15
    Atiemo, K.
    Maddur, H.
    Zhao, L.
    Skaro, A.
    Montag, S.
    VanWagner, L.
    Goel, S.
    Kho, A.
    Kang, R.
    Holl, J.
    Abecassis, M.
    Levitsky, J.
    Kulik, L.
    Ladner, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 677 - 678
  • [22] Model for end-stage liver disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis
    Northup, PG
    Wanamaker, RC
    Lee, YD
    Adams, RB
    Berg, CL
    ANNALS OF SURGERY, 2005, 242 (02) : 244 - 251
  • [23] A novel frailty index improves risk prediction of waitlist mortality over the model for end-stage liver disease score alone
    Fan, Heng
    Zhu, Jian-hua
    HEPATOLOGY, 2018, 67 (05) : 2059 - 2059
  • [24] Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score
    Angermayr, B.
    Luca, A.
    Konig, F.
    Bertolini, G.
    Ploner, M.
    Gridelli, B.
    Ulbrich, G.
    Reiberger, T.
    Bosch, J.
    Peck-Radosavljevic, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (01) : 65 - 71
  • [25] Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With Placebo
    Frenette, Catherine T.
    Morelli, Giuseppe
    Shiffman, Mitchell L.
    Frederick, R. Todd
    Rubin, Raymond A.
    Fallon, Michael B.
    Cheng, Jason T.
    Cave, Matt
    Khaderi, Saira A.
    Massoud, Omar
    Pyrsopoulos, Nikolaos
    Park, James S.
    Robinson, James M.
    Yamashita, Mason
    Spada, Alfred P.
    Chan, Jean L.
    Hagerty, David T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (04) : 774 - +
  • [26] Association of Model for End-Stage Liver Disease Score With Mortality in Emergency General Surgery Patients
    Havens, Joaquim M.
    Columbus, Alexandra B.
    Olufajo, Olubode A.
    Askari, Reza
    Salim, Ali
    Christopher, Kenneth B.
    JAMA SURGERY, 2016, 151 (07)
  • [27] Comparison of Mortality Prediction Between the Model for End-Stage Liver Disease-3.0 (MELD-3.0) and the Model for End-Stage Liver Disease-Lactate (MELD-La) in Korean Patients with Liver Cirrhosis
    Yoo, Seung-Kang
    Kim, Jeong-Han
    Choe, Won-Hyeok
    Kwon, So-Young
    MEDICINA-LITHUANIA, 2025, 61 (03):
  • [28] Model for End-Stage Liver Disease score predicts mortality in critically ill cirrhotic patients
    Boone, M. Dustin
    Celi, Leo A.
    Ho, Ben G.
    Pencina, Michael
    Curry, Michael P.
    Lior, Yotam
    Talmor, Daniel
    Novack, Victor
    JOURNAL OF CRITICAL CARE, 2014, 29 (05) : 881.e7 - 881.e13
  • [29] Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of end-stage liver disease (MELD) score predicts perioperative mortality
    Swee H. Teh
    John Christein
    John Donohue
    Florencia Que
    Michael Kendrick
    Michael Farnell
    Stephen Cha
    Patrick Kamath
    Raymond Kim
    David M. Nagorney
    Journal of Gastrointestinal Surgery, 2005, 9 : 1207 - 1215
  • [30] Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of end-stage liver disease (MELD) score predicts perioperative mortality
    Teh, SH
    Christein, J
    Donohue, J
    Que, F
    Kendrick, M
    Farnell, M
    Cha, S
    Kamath, P
    Kim, R
    Nagorney, DM
    JOURNAL OF GASTROINTESTINAL SURGERY, 2005, 9 (09) : 1207 - 1215